Table 1 Patient’s characteristics and indications for [99mTc]Tc-PSMA-I&S-SPECT/CT
From: [99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
| Â | N | Age [years] | Mean PSA [ng/ml] |
|---|---|---|---|
Total | 210 | 73 (± 8.5) | 50 (± 270) |
Indications | |||
 biochemical recurrence (BCR) | 152 (72.4%) | 72.8 (± 8.8) | 8.7 (± 32) |
 primary staging in high-risk PCa | 12 (5.7%) | 72.7 (± 8.6) | 393 (± 982) |
 restaging in advanced recurrent PCa (antiandrogen therapy, chemotherapy, radiation therapy, 177Lu-PSMA therapy) | 46 (21.9%) | 74.2 (± 8.1) | 101.3 (± 242) |